The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 05, 2025
Filed:
Mar. 08, 2021
Applicant:
Vivoryon Therapeutics N.v., Halle, DE;
Inventors:
Michael Wermann, Halle, DE;
Mirko Buchholz, Halle, DE;
Hans-Ulrich Demuth, Halle, DE;
Daniel Ramsbeck, Halle, DE;
Dagmar Schlenzig, Halle, DE;
Stephan Schilling, Halle, DE;
Assignee:
Vivoryon Therapeutics N.V., Halle, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 259/06 (2006.01); C07C 255/58 (2006.01); C07D 207/16 (2006.01); C07D 213/36 (2006.01); C07D 317/58 (2006.01); C07D 317/64 (2006.01); C07D 319/18 (2006.01);
U.S. Cl.
CPC ...
C07C 259/06 (2013.01); C07C 255/58 (2013.01); C07D 207/16 (2013.01); C07D 213/36 (2013.01); C07D 317/58 (2013.01); C07D 317/64 (2013.01); C07D 319/18 (2013.01);
Abstract
The present invention relates to novel hydroxamic acid derivatives as inhibitors of meprin β and/or α, pharmaceutical compositions comprising such compounds, methods for treatment or prophylaxis of diseases or conditions, especially such that are related to meprin β and/or α, and compounds and pharmaceutical compositions for use in such methods.